Evidence map›Paper›PMID 24848795›Full record

ArticlePloS one2014

Repetitive long-term hyperbaric oxygen treatment (HBOT) administered after experimental traumatic brain injury in rats induces significant remyelination and a recovery of sensorimotor function.

Klaus Kraitsy, Muammer Uecal, Stefan Grossauer, Lukas Bruckmann, Florentina Pfleger, Stefan Ropele, Franz Fazekas, Gerda Gruenbacher, Silke Patz, Markus Absenger and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Differences in Cognitive Function of Rats with Traumatic Brain Injuries Following Hyperbaric Oxygen Therapy.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Klaus KraitsyResearch Unit for Experimental Neurotraumatology, Medical University of Graz, Graz, Austria.
Muammer UecalResearch Unit for Experimental Neurotraumatology, Medical University of Graz, Graz, Austria.
Stefan GrossauerDepartment of Neurosurgery, Medical University of Graz, Graz, Austria.
Lukas BruckmannDepartment of Neurosurgery, Medical University of Graz, Graz, Austria.
Florentina PflegerResearch Unit for Experimental Neurotraumatology, Medical University of Graz, Graz, Austria.
Stefan RopeleClinical Division of General Neurology, Medical University of Graz, Graz, Austria.
Franz FazekasClinical Division of General Neurology, Medical University of Graz, Graz, Austria.
Gerda GruenbacherResearch Unit for Experimental Neurotraumatology, Medical University of Graz, Graz, Austria.
Silke PatzResearch Unit for Experimental Neurotraumatology, Medical University of Graz, Graz, Austria.
Markus AbsengerCore Facility Microscopy, Centre for Medical Research, Medical University of Graz, Graz, Austria.
Christian PorubskyDivision of Thoracic and Hyperbaric Surgery, Department of Surgery, Medical University of Graz, Graz, Austria.
Freyja Smolle-JuettnerDivision of Thoracic and Hyperbaric Surgery, Department of Surgery, Medical University of Graz, Graz, Austria.
Irem TezerDivision of Thoracic and Hyperbaric Surgery, Department of Surgery, Medical University of Graz, Graz, Austria.
Marek MolcanyiDepartment of Neurosurgery, University of Cologne, Cologne, Germany; Institute of Neurophysiology, University of Cologne, Cologne, Germany.
Ulrike FaschingResearch Unit for Experimental Neurotraumatology, Medical University of Graz, Graz, Austria.
Ute SchaeferResearch Unit for Experimental Neurotraumatology, Medical University of Graz, Graz, Austria.
Medical University of Graz · ATUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cells in the central nervous system rely almost exclusively on aerobic metabolism. Oxygen deprivation, such as injury-associated ischemia, results in detrimental apoptotic and necrotic cell loss. There is evidence that repetitive hyperbaric oxygen therapy (HBOT) improves outcomes in traumatic brain-injured patients. However, there are no experimental studies investigating the mechanism of repetitive long-term HBOT treatment-associated protective effects. We have therefore analysed the effect of long-term repetitive HBOT treatment on brain trauma-associated cerebral modulations using the lateral fluid percussion model for rats. Trauma-associated neurological impairment regressed significantly in the group of HBO-treated animals within three weeks post trauma. Evaluation of somatosensory-evoked potentials indicated a possible remyelination of neurons in the injured hemisphere following HBOT. This presumption was confirmed by a pronounced increase in myelin basic protein isoforms, PLP expression as well as an increase in myelin following three weeks of repetitive HBO treatment. Our results indicate that protective long-term HBOT effects following brain injury is mediated by a pronounced remyelination in the ipsilateral injured cortex as substantiated by the associated recovery of sensorimotor function.

Indexed as

Hyperbaric OxygenationPsychomotor PerformanceRecovery of FunctionAnimalsBrainBrain InjuriesEvoked PotentialsMaleMyelin SheathRatsRats, Sprague-DawleyTime Factors

Identifiers

PMID24848795
PMCPMC4029808
OpenAlexW2056727674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.